Literature DB >> 28778553

Thought, language, and communication deficits and association with everyday functional outcomes among community-dwelling middle-aged and older adults with schizophrenia.

Anjana Muralidharan1, Anastasia Finch2, Christopher R Bowie3, Philip D Harvey4.   

Abstract

Older adults with schizophrenia experience poorer community integration and social functioning compared to same-age peers with no mental health disorders; these individuals are at elevated risk for functional decline and early institutionalization in long-term care facilities. Deficits in thought, language, and communication (TLC; that is, thought disorder and alogia) are core features of schizophrenia and may worsen with age; however, little research focuses on the functional sequelae of these impairments among older adults with schizophrenia. The present study aimed to examine the relationships among age, TLC deficits, and functional outcomes in a sample of community-dwelling middle-aged and older adults with schizophrenia (N = 245; ages 40-85). Participants completed assessments of symptoms, neurocognition, TLC deficits, and functional outcomes. Two different categories of TLC deficits were examined: verbal underproductivity (i.e., alogia) and disconnected speech. Regression analyses, controlling for gender, age, Veteran status, smoking status, cognitive impairment, and symptom severity, found that disconnected speech predicted occupational functioning, while verbal underproductivity predicted capacity to communicate skillfully in semi-structured social situations, as well as community functioning across interpersonal, occupational, and everyday living domains. Exploratory mediation analyses found significant indirect effects of age, through TLC deficits, on certain functional outcomes. Targeted training to improve TLC deficits, especially verbal underproductivity, among older adults with schizophrenia could have downstream effects on community functioning, improving outcomes for a vulnerable group. Published by Elsevier B.V.

Entities:  

Keywords:  Alogia; Community functioning; Functional capacity; Older adults; Schizophrenia; Thought disorder

Mesh:

Year:  2017        PMID: 28778553      PMCID: PMC5794645          DOI: 10.1016/j.schres.2017.07.017

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  22 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

3.  Validating the measurement of real-world functional outcomes: phase I results of the VALERO study.

Authors:  Philip D Harvey; Tenko Raykov; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson
Journal:  Am J Psychiatry       Date:  2011-05-15       Impact factor: 18.112

4.  Social skills performance assessment among older patients with schizophrenia.

Authors:  T L Patterson; S Moscona; C L McKibbin; K Davidson; D V Jeste
Journal:  Schizophr Res       Date:  2001-03-30       Impact factor: 4.939

5.  The longitudinal course of thought disorder in geriatric patients with chronic schizophrenia.

Authors:  Christopher R Bowie; Irene Tsapelas; Joseph Friedman; Michael Parrella; Leonard White; Philip D Harvey
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

6.  Thought disorder and psychosocial functioning in schizophrenia: the concurrent and predictive relationships.

Authors:  J M Racenstein; D Penn; M Harrow; R Schleser
Journal:  J Nerv Ment Dis       Date:  1999-05       Impact factor: 2.254

Review 7.  Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia.

Authors:  Dilip V Jeste; Owen M Wolkowitz; Barton W Palmer
Journal:  Schizophr Bull       Date:  2011-05       Impact factor: 9.306

8.  Increased risk of nursing home admission among middle aged and older adults with schizophrenia.

Authors:  Alice O Andrews; Stephen J Bartels; Haiyi Xie; William J Peacock
Journal:  Am J Geriatr Psychiatry       Date:  2009-08       Impact factor: 4.105

9.  Communication abnormalities predict functional outcomes in chronic schizophrenia: differential associations with social and adaptive functions.

Authors:  Christopher R Bowie; Philip D Harvey
Journal:  Schizophr Res       Date:  2008-06-20       Impact factor: 4.939

10.  Mental illness and use of home care nationally in the U.S. Department of Veterans Affairs.

Authors:  Edward Alan Miller; Robert A Rosenheck
Journal:  Am J Geriatr Psychiatry       Date:  2007-12       Impact factor: 4.105

View more
  4 in total

1.  Differences in fractal patterns and characteristic periodicities between word salads and normal sentences: Interference of meaning and sound.

Authors:  Jun Shimizu; Hiromi Kuwata; Kazuo Kuwata
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

2.  The link between formal thought disorder and social functioning in schizophrenia: A meta-analysis.

Authors:  Matthew P Marggraf; Paul H Lysaker; Michelle P Salyers; Kyle S Minor
Journal:  Eur Psychiatry       Date:  2020-03-23       Impact factor: 5.361

3.  Metacognitive preserved generation strategy benefits for both younger and elderly participants with schizophrenia.

Authors:  Marie Izaute; Flavien Thuaire; Alain Méot; Fabien Rondepierre; Isabelle Jalenques
Journal:  PLoS One       Date:  2020-11-20       Impact factor: 3.240

Review 4.  Metacognition, social cognition, and mentalizing in psychosis: are these distinct constructs when it comes to subjective experience or are we just splitting hairs?

Authors:  P H Lysaker; S Cheli; G Dimaggio; B Buck; K A Bonfils; K Huling; C Wiesepape; J T Lysaker
Journal:  BMC Psychiatry       Date:  2021-07-02       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.